Newamsterdam Pharma Stock In The News
| NAMS Stock | 21.77 0.99 4.76% |
Our overall analysis of NewAmsterdam Pharma's news coverage and content from conventional and social sources shows investors' bearish mood towards NewAmsterdam Pharma. The specific impact of NewAmsterdam Pharma news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of NewAmsterdam Pharma's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using NewAmsterdam Pharma headlines in addition to utilizing other, more conventional financial analysis modules. Check out NewAmsterdam Pharma Backtesting and NewAmsterdam Pharma Hype Analysis. For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.
NewAmsterdam |
NewAmsterdam Pharma Today Top News and Investor Outlook
NewAmsterdam Pharma Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide NewAmsterdam and other traded companies coverage with news coverage. We help investors stay connected with NewAmsterdam headlines for the 31st of January to make an informed investment decision based on correlating the impacts of news items on NewAmsterdam Stock performance. Please note that trading solely based on the NewAmsterdam Pharma hype is not for everyone as timely availability and quick action are needed to avoid losses.
NewAmsterdam Pharma stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the NewAmsterdam earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about NewAmsterdam Pharma that are available to investors today. That information is available publicly through NewAmsterdam media outlets and privately through word of mouth or via NewAmsterdam internal channels. However, regardless of the origin, that massive amount of NewAmsterdam data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of NewAmsterdam Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NewAmsterdam Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NewAmsterdam Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NewAmsterdam Pharma alpha.
NewAmsterdam Largest EPS Surprises
Earnings surprises can significantly impact NewAmsterdam Pharma's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-07 | 2024-06-30 | -0.58 | -0.41 | 0.17 | 29 | ||
2023-11-13 | 2023-09-30 | -0.8731 | -0.5642 | 0.3089 | 35 | ||
2024-11-06 | 2024-09-30 | -0.5 | -0.18 | 0.32 | 64 | ||
2024-05-08 | 2024-03-31 | -0.53 | -1.06 | -0.53 | 100 | ||
2023-08-07 | 2023-06-30 | -0.42 | -1.01 | -0.59 | 140 | ||
2022-10-18 | 2022-09-30 | -1.14 | -0.2693 | 0.8707 | 76 |
NewAmsterdam Pharma Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to NewAmsterdam Pharma Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
30th of January 2025
JPMorgan Chase Co. Has 371,000 Stock Holdings in NewAmsterdam Pharma - MarketBeat at news.google.com
27th of January 2025
Disposition of 23815 shares by Douglas Kling of NewAmsterdam Pharma at 23.46 subject to Ru... at MacroaxisInsider
15th of January 2025
NewAmsterdam Pharma Company N.V. Analysts Recommend This 52-Week High Stocks Now at finance.yahoo.com
8th of January 2025
Acquisition by Smither John W of 6960 shares of NewAmsterdam Pharma subject to Rule 16b-3 at MacroaxisInsider
30th of December 2024
NewAmsterdam Pharmas SWOT analysis obicetrapib stock poised for cardiovascular market impa... at investing.com
26th of December 2024
Disposition of 33438 shares by Forgrowth Nap B.v. of NewAmsterdam Pharma at 26.0072 subjec... at MacroaxisInsider
20th of December 2024
Disposition of 5629 shares by Forgrowth Nap B.v. of NewAmsterdam Pharma at 26.1274 subject... at MacroaxisInsider
18th of December 2024
Disposition of 46210 shares by Forgrowth Nap B.v. of NewAmsterdam Pharma at 26.5496 subjec... at thelincolnianonline.com
12th of December 2024
NewAmsterdam Pharma Announces Pricing of Upsized 416.5 Million Public Offering of Ordinary... at finance.yahoo.com
6th of December 2024
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635 at gurufocus.com
6th of November 2024
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results at finance.yahoo.com
NewAmsterdam Pharma Investors Sentiment
The influence of NewAmsterdam Pharma's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in NewAmsterdam. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to NewAmsterdam Pharma's public news can be used to forecast risks associated with an investment in NewAmsterdam. The trend in average sentiment can be used to explain how an investor holding NewAmsterdam can time the market purely based on public headlines and social activities around NewAmsterdam Pharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
NewAmsterdam Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for NewAmsterdam Pharma's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average NewAmsterdam Pharma's news discussions. The higher the estimated score, the more favorable is the investor's outlook on NewAmsterdam Pharma.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NewAmsterdam Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NewAmsterdam Pharma's short interest history, or implied volatility extrapolated from NewAmsterdam Pharma options trading.
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.